Literature DB >> 28483222

Endoscopic management of bilateral vocal fold paralysis in newborns and infants.

Sahba Sedaghat1, Mario Tapia2, Felipe Fredes2, Pablo Rojas3.   

Abstract

INTRODUCTION: Bilateral vocal cord paralysis in adducted position (BVCPAd) is a severe cause of airway obstruction and usually debuts with stridor and airway distress necessitating immediate intervention. Tracheostomy has long been the gold standard for treating this condition, but has significant associated morbidity and mortality in pediatric patients. New conservative procedures have emerged to treat this condition thus avoiding tracheostomy, like endoscopic anterior and posterior cricoid split (EAPCS). The objective of this paper was to review our experience with EAPCS in newborns and infants.
METHODS: Prospective study involving patients undergoing endoscopic EAPCS for symptomatic BVCPAd. The primary outcomes were tracheostomy avoidance and resolution of airway symptoms.
RESULTS: Three patients underwent EAPCS between January 2016 and December 2016. All patients stayed at least 7 days in the Intensive Care Unit (ICU) intubated. All patients presented complete resolution of their symptoms due to airway obstruction, without the need for tracheostomy.
CONCLUSION: EAPCS is a novel and effective alternative to treat BVCPAd in patients under 1 year old. Our study is an initial experience; more cases are required to identify the real impact and benefits of this technique and to determine the proper selection of patients.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Airway; Bilateral vocal cord paralysis; Cricoid split; Stridor; Vocal cord immobility

Mesh:

Year:  2017        PMID: 28483222     DOI: 10.1016/j.ijporl.2017.03.021

Source DB:  PubMed          Journal:  Int J Pediatr Otorhinolaryngol        ISSN: 0165-5876            Impact factor:   1.675


  1 in total

1.  Endoscopic coblation-assisted and partial arytenoidectomy for infants with idiopathic bilateral vocal cord paralysis.

Authors:  Letian Tan; Chao Chen; Qi Li
Journal:  Medicine (Baltimore)       Date:  2022-01-28       Impact factor: 1.889

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.